Objective: Cancer patients experience reproductive concerns from diagnosis through to survivorship. However, research has yet to investigate the degree of fertility-related psychological distress at different treatment time points: diagnosis, treatment, and survivorship. Currently, cancer patients are offered fertility counselling at the time of diagnosis, to assist fertility preservation decision making. A systematic review of the short-term and long-term psychological impact of infertility in cancer patients would inform on an improved, longitudinal model of psychological care. Results: A total of 47 papers were included within the final review. Fertility-related psychological distress persists from diagnosis through to survivorship, with cancer patients reporting a range of negative emotional experiences brought about by threatened infertility. In survivorship, reproductive concerns, unfulfilled desire for a child, nulliparous status, and early menopause were linked to higher rates of mental health disorders and psychological distress.
survivors of childhood cancer also at risk of delayed pubertal growth. 4 Cancer patients whom are of reproductive age (generally defined as those persons <45 years of age) may not have had the opportunity to complete their family prior to cancer diagnosis and as such may report heightened reproductive concerns. 5, 6 The term reproductive concerns is utilised in the literature (at times interchangeably with fertility concerns) to reflect concerns regarding a wide range of fertility factors. These may include fertility potential, pregnancy, and future parenthood, recorded either by brief patient self-report 7, 8 or via a standardised measure. 9 Reproductive concerns can persist throughout cancer treatment into survivorship and impact on areas of later life development, such as sexual health, body image, or relationships, [10] [11] [12] and lead to lower quality of life. 13 However, there is no systematic review of the literature on the psychological impact of interrupted fertility and the association between psychological distress and reproductive concerns. Yet this information would assist in informing on an improved model of psychological support for cancer patients.
Literature suggests that when cancer or cancer treatment impact on fertility potential, specialised fertility psychological interventions and counselling may be beneficial in alleviating patient's distress, assisting treatment decision-making processes, and providing necessary reproductive education. [14] [15] [16] [17] Models of psychological support offer assistance at the time of diagnosis to assist in fertility preservation decision making. 18 However, psychological care does not often extend past this point, leading cancer survivors to report unmet fertility psychological care needs in survivorship. 19, 20 Within a cancer population, evidence suggests that fertility can be related to psychological distress, 21, 22 a term utilised in the literature to indicate both a general negative emotional response 7 and a specific measurement of a mental health difficulty. 22 As such, the term fertility-related psychological distress is utilised in this manuscript, to refer to any psychological distress that is either seen as a direct reaction to, or directly associated with, fertility potential, a fertility treatment, or a reproductive concern of a cancer patient. For example, both male and female patients report increased concern, worry, and feelings of anxiety surrounding uncertain fertility status. 23 Similarly, research indicates that cancer survivors with an unfulfilled pretreatment desire to have a child and heightened reproductive concerns have an increased risk of depression and poorer mental health. 21, 24 To accurately assess the impact of fertility-related psychological distress in reproductive age cancer patients, an analysis must take into account stage of cancer treatment. 25 At the time of cancer diagnosis, fertility interventions are likely to occur (with recommendations for fertility discussions, referral to a fertility specialist, and fertility preservation) that require timely decision making. [26] [27] [28] However, as oncological treatment progresses, the emotional impact of reproductive concerns may heighten. 11 As such, patient's experiences of fertilityrelated psychological distress may alter based on stage of cancer treatment. For example, around diagnosis, patients report shock, devastation, sadness, and frustration at potential infertility, 29, 30 elevated emotional concerns related to choice of cancer treatment and impact to future reproductive potential, 31 and heightened anxiety during fertility consultations. 32 Fertility-related psychological distress may then persist into survivorship, with research indicating that persistent sadness, grief, 33 anxiety, depression, panic, and social isolation can remain for up to 20 years post diagnosis. 34 It therefore appears important that appropriate psychological care is in place to support cancer patients throughout the entirety of their cancer journey.
Previous reviews addressing reproductive concerns or needs within a young cancer population have limited analyses to female breast cancer patients 35, 36 or were focused on child bearing, 37 parenthood, 38 or the psychological impact of fertility preservation alone.
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These reviews have not explored fertility-related psychological distress mapped to time points of a cancer journey; diagnosis, treatment, and survivorship; and explored how fertility-related psychological distress is related to reproductive concerns. Yet this knowledge is vital if we are to accurately understand the psychological impact of impaired fertility potential in young cancer patients across the lifespan and develop targeted psychological support. As such, the aim of this systematic review is to explore the fertility-related psychological distress and the short-term and long-term psychological impact of interrupted fertility. This review will provide the opportunity to inform on better patient-oriented treatment and care, for cancer patients and survivors in relation to their fertility.
| METHOD
A systematic search of online databases Medline, EMBASE, PSYCH Info, Web of Science, and SCOPUS was undertaken in January 2018 using search terms (see Supplementary Table S1 ) to reflect cancer, psychological distress, and fertility. Screening of reference lists and review articles was undertaken to accrue additional potentially relevant manuscripts. A total of 708 articles were identified via the database searches and additional manual screening after the deletion of duplicates (see Figure 1 ). All studies were visually screened at title and abstract level by a single reviewer, with the remaining 111 articles full-text screened. A second reviewer independently read a sample of the remaining articles to determine inclusion eligibility, with any discrepancies on inclusion discussed between the two reviewers.
Inclusion criteria were met when (1) patients were of reproductive age at the time of a cancer diagnosis or during data collection (age range or mean age ≤ 45 years) as these participants were most likely impacted by the effects of infertility, (2) data reported on fertilityrelated psychological distress, (3) data were described using quantitative or qualitative methods, (4) the manuscript was in the form of a peer-reviewed journal article written in English language. Fertilityrelated psychological distress was quantified as either a patient's emotional response to actual or threatened infertility, a standardised measure of fertility-related psychological distress, or a standardised measure of psychological distress that reported a direct association with a fertility treatment, fertility potential, or reproductive concern.
Articles reporting on sexual health outcomes, reproductive function, or reproductive concerns alone without reference to psychological distress, alongside those reporting on psychological distress not associated with fertility, were excluded from analyses. In order to accurately capture the breadth of cancer patient's experiences, no limitations were placed on gender, cancer types, or time since diagnosis. In total, 47 papers describing 46 separate studies were eligible for further analysis.
The quality of final studies was assessed using the Mixed Methods Appraisal Tool (MMAT), 40 a valid instrument for testing mixed method reviews. 41 The MMAT assesses quality on the domains of sampling, measurements, completion of data, and bias, of either qualitative or quantitative research. Scores on the MMAT vary from 25% (one criteria met) to 100% (all criteria met). All included studies
were of sound quality (75%-100%). Table 2 reflects the key features and data extracted from each study on fertility-related psychological distress and full report of reproductive concerns. Separate papers reporting on the same study are combined into a single row within the data extraction table.
| RESULTS

Of
Only 11 of the included papers had a primary focus on the measurement of fertility-related psychological distress, with most papers primarily focusing on the experience of fertility (n = 19), reproductive concerns (n = 4), sexual function (n = 4), or quality of life/general psychosocial well-being (n = 9).
Papers were divided by treatment timepoint to ascertain psychological impact of infertility throughout patient's cancer journey (see Supplementary Table S3 for fertility-related psychological distress and reproductive concerns by study, across treatment time points).
Eight papers reported on patient experiences at the time of diagnosis, and six from the time of recent diagnosis throughout treatment. The majority of studies reported on the survivorship period; from early survivorship (approx. 2-5 years post diagnosis; n = 8), survivorship generally (timeframe not specified; n = 6), or late survivorship (approx. 5-15 years post diagnosis; n = 19).
| Diagnosis and treatment
| Fertility-related psychological distress
The risk of treatment-induced infertility in newly diagnosed patients was at times as distressing and devastating to patients as the initial cancer diagnosis. 29, 42 Both current patients and survivors recalled feeling a range of negative emotions at the prospect of potential infertility at the time of diagnosis, including feeling scared, frightened, overwhelmed, sad, depressed, frustrated, and losing control. 29, 30, 42 Both adolescent mixed gender (11-20 years) and female breast cancer patients reported frequent worries related to fertility (57%). 8, 43, 44 Female patients presenting for fertility preservation treatment at the time of cancer diagnosis report poorer mental health compared with infertile noncancer patients, including significantly greater depression (44% vs 14% scored >16 on the Centre or Epidemiologic
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Studies Depression Scale; CES-D), anxiety (not specific to fertility:
62% vs 27% scored ≥39 on the State Trait Anxiety Inventory (STAI); P < 0.05), and commensurate infertility stress (on the Fertility Problem Inventory (FPI)). 45 Interestingly, these patients underreported their symptoms of depression and anxiety when self-reporting (indicating 13% and 9% incidence of these mental health disorders, respectively).
Similarly, one-third of female cancer patients presenting for ovarian hyperstimulation endorsed current symptoms of depression and anxiety that impaired functioning. 46 However, there was no data to indicate differences in levels of distress between those who had or had not undertaken fertility preservation at the time of diagnosis, or prevalence of mental health disorders in male patients accessing fertility preservation treatment.
Psychological distress may persist throughout early stages of fertility and oncological treatment and then remit, opposed to reproductive concerns which remain elevated. 31, 45, [47] [48] [49] Elevated depression (CES-D) and anxiety (STAI; P < 0.05) persisted throughout fertility preservation for cancer patients, despite both mood difficulties increasing in a noncancer infertile sample. 45 Elevated depression (CES-D) and fertility-related trauma (on the Impact of Event Scale (IES), a measure designed to indicate likelihood of posttraumatic stress disorder) were associated with cervical surgical treatment regardless of surgery type (radical trachelectomy or hysterectomy); however, in both groups, this distress lessened over time (both subclinical by 12 months). 47 Conversely, for breast and cervical cancer patients, concern about conception, future pregnancy, and menopause remained high presurgery and postsurgery (90%-100%) 31 ,47 persisted up to 2 years,(73%) 47 , associated with feelings of worry, anger, shock loss, and fear.
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| Reproductive concerns
For breast cancer patients, greater reproductive concerns was associated with desire for a child in the future (P < 0.0001), number of prior pregnancies (P < 0.01), and prior difficulty conceiving (P = 0.08, mean age 32 at diagnosis). 8 Desire for a child in the future was similarly important for adolescent patients, associated with higher levels of concern and anticipated feelings of sadness, 44 even though these patients reported a lack of current desire for parenthood at the time of diagnosis. 50 Indeed, emotional responses to reproductive concerns may differ based on patient age; with rage and injustice reported by younger female patients (18-25 years) at thoughts of potential infertility, while future parenthood was a concern more frequently expressed by older patients (aged [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] . 32 In one sample of young ovarian cancer patients (mean age 22 years), 52% (n = 12) reported fear that their disease would damage their reproductive potential; however, 39%
(n = 9) of this sample were not concerned about the effect of cancer treatment on their future offspring. 51 Reproductive concerns were important for treatment decision making in almost half (41%) of one sample of newly diagnosed cervical cancer patients. 31 Similarly, a large sample of breast cancer patients self-reported concern about future fertility had impacted on their oncological treatment decision making (29%, n = 657), with patients more likely to report this difficulty when they also reported a desire for a future child (P < 0.0001), a history of severe depressive symptoms (P = 0.03), and fertility difficulties prior to diagnosis (P = 0.01). 8 Regret associated with fertility preservation treatment choices increased over time (12-18 months) in a second sample of breast cancer patients who had initially reported no concerns, when fertility preservation choices in early diagnosis had not been utilised. 48 
| Fertility psychological interventions
Across all included studies, only three papers reported on a psychological intervention or implementation of fertility counselling/psychological support, all implemented at the time of cancer diagnosis. 32, 52, 53 A psychosexual development intervention for newly diagnosed adolescent male and female patients was reported to reduce distress and emotional and sexual concerns 3 months postintervention, compared with waitlist controls. 52 Fertility counselling undertaken by a fertility specialist prior to cancer treatment opposed to oncologist alone was associated with better psychological health, with those who undertook counselling and proceeded with fertility preservation also reporting reduced regret, compared with those who did not proceed. 53 Similarly, the presence of a psychologist was deemed a helpful opportunity to explore painful feelings and concerns surrounding infertility at the time of fertility preservation specialist consultation for female patients. 32 However, this study also indicated 76 and there was a strong positive association between heightened trauma (IES) and depression (CES-D; P < 0.0001). 72 No studies reported on the prevalence of trauma in male-only samples.
Emotional well-being, opposed to psychological distress, appears to be a separate construct and not simply the inverse of emotional ill health. For example, greater emotional well-being was linked to those cancer patients whose fertility had not been impeded 13 ; however, it was not associated with fertility impacting cancer treatment, patient perceptions of infertility, or desiring a future child. 70 
| Reproductive concerns
Patients report both constant and persistent reproductive concerns into survivorship 48, 62 that disrupt the life narrative, with a realisation that cancer would affect them for the rest of their lives 23 leading to a future with no meaning or purpose, 55, 65 lack of normalcy and a feeling of being "damaged goods", inadequate or that their body was "disgusting", or simply affected feelings about their self (25%-27%). 43, 59, 64, 65, 67 Uncertainty regarding fertility status, loss of control of reproductive status, reminders of infertility, or accepting infertility status being particularly emotionally difficult for patients. 7,13,55 It appears that reproductive concerns are independent from actual ability to have children, with male testicular cancer patients having higher levels of self-reported fertility distress and also perceiving greater difficulty in fathering children, compared with healthy controls, despite being more likely to have fathered children. 60 Reproductive concerns were associated with depression (not specific to fertility: P < 0.0001-P = 0.0002), 74, 75 with odds of "moderate"
to "severe" depression 1.3 times higher with every five unit increase on the Reproductive Concerns After Cancer (RCAC) scale, 75 alongside poorer mental health (QOL, P < 0.001), more cancer specific distress (P < 0.001), and significantly poorer quality of life. 13 It therefore appears likely that for cancer survivors who report persistent and heightened reproductive concerns in survivorship, their likelihood for development of a mental health disorder is increased.
Unfulfilled desire for a child and interrupted childbearing (reported in 17% of male and 30% of female survivors) increase the risk for poorer mental health (not specific to fertility: P = 0.024), 21 more fertility-related trauma symptoms (IES intrusion and avoidance subscales, P < 0.001), higher reproductive concerns (RCS, P < 0.001), 22, 74 greater cancer distress (P < 0.01), and lower psychological well-being (not specific to fertility: P < 0.001). 13 Approximately 50% of survivors with a pretreatment desire for a child report persistent unfulfilled desires, and this cohort tended to be younger age and nulliparous. 21 Similarly, unfulfilled desire for a child in those who are nulliparous is also associated with depression (not specific to fertility: CES-D; P = 0.03). 74 Childless status is also important, associated with greater distress about fertility in male survivors 56, 57 and greater fertility-related trauma (IES, P < 0.01) and reproductive concerns (RCS, P < 0.001) in female survivors with primary (n = 38) opposed to secondary infertility (n = 39). 22 Similarly, depression (not specific to fertility: CES-D) was associated with those who had no children prior to a cancer diagnosis (P = 0.004) 72, 74 and greater cancer-related trauma reported in those who had been advised to terminate a pregnancy at diagnosis (IES; P = 0.02). 76 Conversely, having children appears to be protective, with women scoring lower in depression (not specific to fertility: CES-D) if they had children (P = 0.047), 72 had one or more live births (P = 0.0007), or attempted a pregnancy compared with avoiding pregnancy after cancer (P = 0.004). 74 Risk of depression in postmenopausal survivors (opposed to those with ovarian function) may be up to 3.4 times (P < 0.001-P = 0.02). 24, 74 Up to one-third of female survivors reported being bothered by menopausal symptoms, 72 causing fear and anxiety, 65 with greater impact ("bother") of menopausal symptoms associated with higher cancer-related trauma and depression (IES, P < 0.001; CES-D, P < 0.0001-0.001). 72 Another study reported a weak association between poorer mental health (Mental Component Summary Scale (MCS); P = 0.10) in young female breast cancer patients (24-34 years) who had experienced early menopause postoncological treatment compared with those whom had not, and no significant association in older patients (34-51 years), 33 suggesting that younger patients may be more emotionally impacted by early menopause. Sexual dysfunction in young adult male and female survivors also indicated a significantly greater risk of depression, anxiety disorders (>13 years at diagnosis, mean age 27 years at time of study; score of ≥57 on the BSI) 71 or self-reported distress (18-31 years at time of study). 23 
| Oncofertility treatment and care
Cancer site and treatment type influenced experience of fertilityrelated psychological distress. In male and female cancer survivors, a cancer site close to reproductive organs was associated with heightened anxiety, 50 while having chemotherapy or surgery was related to elevated distress about fertility in male patients, compared with those who had not. 60 Similarly, greater symptoms of depression were reported in irradiated compared with cervical cancer patients treated with surgery or healthy controls. 73 Patient's experience with oncofertility care was also important in the expression of psychological distress. Lack of fertility support, patient knowledge, or provision of fertility information was associated with experiences of uncertainty and concern, alongside higher levels of depression (not specific to fertility: CES-D) and cancer or fertilityrelated trauma (IES, P < 0.01-P = 0.02) 59, 61, 68, 76 Discussing fertility with clinicians or family 7,29 brought about negative emotional responses when patients felt that fertility was not given full consideration. 50 Feelings of anxiety and fear also led to avoidance of ongoing fertility testing in male and female childhood cancer survivors. Of particular note, the reproductive concern of unfulfilled desire to have a child in female patients was linked to significantly more trauma, depression, poorer mental health, higher reproductive concerns, and lower sexual satisfaction, compared with those without interrupted childbearing, with greatest distress amongst those who had no children prior to a cancer diagnosis. This finding is particularly important within a reproductive-aged cancer population who are unlikely to have had the opportunity to complete their family prior to a cancer diagnosis.
Indeed, greater disruption to family planning by infertility may also account for why younger cohorts within a reproductive age bracket experience greater distress. It is therefore important that clinicians assess desire for a child/more children within survivorship, alongside biological reproductive symptoms, to ensure patients are able to access necessary fertility counselling and psychological support.
The results of this systematic review suggest that it is vital that both male and female cancer patients of a reproductive age have access to fertility-related psychological care if desired. Limited data available suggests that the implementation of fertility interventions in psychological support at diagnosis is beneficial for patient's mental health, 32, 52, 53 and lack of support or information throughout survivorship is detrimental. 59, 61, 68, 76 Psychological care that is positioned throughout the cancer journey may better manage persistent fertility-related psychological distress and the ongoing uncertainty and distress associated with actual or threatened impaired fertility.
This view is consistent with previous research, stating both the perceived patient benefit and necessity of psychological services within oncofertility care.
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| Limitations
Although this review captures a wide range of studies, the majority did not focus exclusively on fertility-related psychological distress or reproductive concerns. In the majority of cases, each study reports a small quantity of data which was captured as part of a broader analy- 
| Clinical implications
Based on the results of this review, a number of treatment recommendations can be suggested in order to better support patients with their psychological health within oncofertility care. If fertility-related psychological distress persists into survivorship, it is worthwhile considering the application of psychological interventions throughout the entire cancer journey as an improved model of psychological care. It is recommended that the provision of specialised mental health treatment be available to those patients that report significant levels of distress. This psychological specialised assistance may be integrated into current fertility counselling practices, or may need to be accessed as an additional service, if beyond the scope of training of a fertility counselling clinician. Therefore, fertility treating centres should ensure they are able to access or refer to appropriate psychological services as part of fertility-related care.
It is imperative that patients have ongoing access to fertility services, such as a fertility specialist and fertility preservation. Access to fertility preservation would serve to reduce physical reproductive barriers to later family planning and may assist with the significant distress incurred by those cancer survivors who have not yet had an opportunity to complete their family. Given the provision of fertility information and increased fertility knowledge reduce psychological distress 11 and are important to those with heightened anxiety, 78 the use of fertility preservation decision aids that assist cancer patients in making fertility preservation treatment choices is recommended, to complement these services.
It is also recommended that ongoing communication about fertility and general supportive care be offered to all patients throughout all stages of cancer treatment. The provision of an ongoing platform for patients to discuss their fertility psychological needs within oncofertility will allow patients to be better supported emotionally, allow clinicians to link patients with specialist services in a timely manner, and thereby reduce the likelihood for the expression of significant mental health difficulties due to infertility.
| Conclusions
The interruption to fertility brought about by cancer and cancer treatment is inextricably linked to indicators of emotional ill health.
Fertility-related psychological distress is prevalent and persistent within a cancer patient population diagnosed at reproductive age. This distress and concern is related not only to later reproductive function but also to the patient's perception of fertility status and impacts on psychological functioning well into survivorship.
Improvements in psychological support within oncofertility care are therefore not only beneficial but also imperative to reduce suffering at the time of diagnosis and into survivorship. When the provision of cancer treatment impacts fertility potential, there is a duty of care by clinicians to adequately support cancer patients both medically and psychologically. Engagement with this care early in a patient's cancer journey will assist in the ongoing facilitation of psychological support as warranted throughout the cancer journey. When patients report with significant clinically elevated levels of psychological distress, it is important that they have access to specialised psychological services.
Ongoing fertility-related supportive care, such as via the provision of fertility information, discussions of fertility with patients, provision of counselling, or fertility-related education, may all positively influence or mediate the level of fertility-related psychological distress that patients experience. The provision of oncofertility care that is grounded in psychologically supportive practice will benefit patients greatly, in being able to respond to and cope with the psychological stressors inherent in interrupted fertility.
FUNDING SOURCE
